Invention Grant
- Patent Title: Crystal form of estrogen receptor inhibitor and preparation method therefor
-
Application No.: US16648943Application Date: 2018-09-25
-
Publication No.: US11034653B2Publication Date: 2021-06-15
- Inventor: Huijun He , Jianyu Lu , Weidong Li , Shenyi Shi , Zhijuan Chen , Charles Z. Ding , Lihong Hu , Tie-Lin Wang , Jiaqiang Dong
- Applicant: LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD. , SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
- Applicant Address: CN Shanghai; CN Shandong
- Assignee: LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD.,SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
- Current Assignee: LUOXIN PHARMACEUTICAL (SHANGHAI) CO., LTD.,SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
- Current Assignee Address: CN Shanghai; CN Shandong
- Agency: Dilworth IP, LLC
- Priority: CN201710874782.5 20170925
- International Application: PCT/CN2018/107324 WO 20180925
- International Announcement: WO2019/057201 WO 20190328
- Main IPC: C07D209/18
- IPC: C07D209/18
Abstract:
Disclosed are a crystal form of an estrogen receptor inhibitor and a preparation method therefor, in particular disclosed are a crystal form A of a compound of formula (I) and a preparation method therefor, and the use of the crystal form in the preparation of a drug for treating breast cancer.
Public/Granted literature
- US20200247748A1 CRYSTAL FORM OF ESTROGEN RECEPTOR INHIBITOR AND PREPARATION METHOD THEREFOR Public/Granted day:2020-08-06
Information query
